GAIN THERAPEUTICS INC
GANX stock holders 13F
1 superinvestor reported owning GANX (Common Stock) according to the gurus' 2023 Q3 report.
Top gurus who own (GANX) GAIN THERAPEUTICS INC
The 1 super investor (holders) owning GANX (by the percentage (%) of portfolio) is David Einhorn - Greenlight Capital (0.11%) as of the 2023 Q3 report.
To check the latest activities of the top GANX shareholders between value investors, please click on the "Activity" tab.
To see the historical data of GANX's holders please click on the "2023 Q3" dropdown menu and select the date.
Current price: $1.72 47.56%
Reported hold price*: $3.28
Shares, change to shares, sold shares - split-adjusted.
Reported price - this doesn't represent the actual buy or sell price.
It is the split-adjusted price of the security as of the last day of the reported period.